These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 9829533)
1. Ex vivo fibroblast transduction in rabbits results in long-term (>600 days) factor IX expression in a small percentage of animals. Chen L; Nelson DM; Zheng Z; Morgan RA Hum Gene Ther; 1998 Nov; 9(16):2341-51. PubMed ID: 9829533 [TBL] [Abstract][Full Text] [Related]
2. Long-term expression of human factor IX cDNA in rabbits. Zhou JM; Qiu XF; Lu DR; Lu JY; Xue JL Sci China B; 1993 Nov; 36(11):1333-41. PubMed ID: 8142022 [TBL] [Abstract][Full Text] [Related]
3. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX. Chen L; Perlick H; Morgan RA Hum Gene Ther; 1997 Jan; 8(2):125-35. PubMed ID: 9017417 [TBL] [Abstract][Full Text] [Related]
4. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients. Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366 [TBL] [Abstract][Full Text] [Related]
5. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Yao SN; Smith KJ; Kurachi K Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074 [TBL] [Abstract][Full Text] [Related]
6. Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents. Brauker J; Frost GH; Dwarki V; Nijjar T; Chin R; Carr-Brendel V; Jasunas C; Hodgett D; Stone W; Cohen LK; Johnson RC Hum Gene Ther; 1998 Apr; 9(6):879-88. PubMed ID: 9581910 [TBL] [Abstract][Full Text] [Related]
7. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient. Zhou JM; Dai YF; Qiu XF; Hou GY; Akira Y; Xue JL Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202 [TBL] [Abstract][Full Text] [Related]
8. Stage I clinical trial of gene therapy for hemophilia B. Lu DR; Zhou JM; Zheng B; Qiu XF; Xue JL; Wang JM; Meng PL; Han FL; Ming BH; Wang XP Sci China B; 1993 Nov; 36(11):1342-51. PubMed ID: 8142023 [TBL] [Abstract][Full Text] [Related]
9. Fibroblast transplantation in rats: transduction and function of foreign genes. Neuzil D; Holzman M; Rozga J; Levine J; Moscioni AD; Demetriou AA J Surg Res; 1993 Jun; 54(6):631-7. PubMed ID: 8412074 [TBL] [Abstract][Full Text] [Related]
10. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors. Dai YF; Qiu XF; Xue JL; Liu ZD Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003 [TBL] [Abstract][Full Text] [Related]
11. Expression of biologically active human factor IX in human hematopoietic cells after retroviral vector-mediated gene transduction. Hao QL; Malik P; Salazar R; Tang H; Gordon EM; Kohn DB Hum Gene Ther; 1995 Jul; 6(7):873-80. PubMed ID: 7578406 [TBL] [Abstract][Full Text] [Related]
12. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793 [TBL] [Abstract][Full Text] [Related]
13. Hepatic control elements promote long-term expression of human coagulation factor IX gene in hydrodynamically transfected mice. Kim HS; Kim JC; Lee YK; Kim JS; Park YS J Gene Med; 2011 Jul; 13(7-8):365-72. PubMed ID: 21710610 [TBL] [Abstract][Full Text] [Related]
14. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia. High KA Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929 [TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hurwitz DR; Kirchgesser M; Merrill W; Galanopoulos T; McGrath CA; Emami S; Hansen M; Cherington V; Appel JM; Bizinkauskas CB; Brackmann HH; Levine PH; Greenberger JS Hum Gene Ther; 1997 Jan; 8(2):137-56. PubMed ID: 9017418 [TBL] [Abstract][Full Text] [Related]
16. Appropriate control of ex vivo gene therapy delivering basic fibroblast growth factor promotes successful and safe development of collateral vessels in rabbit model of hind limb ischemia. Ishii S; Koyama H; Miyata T; Nishikage S; Hamada H; Miyatake S; Shigematsu H J Vasc Surg; 2004 Mar; 39(3):629-38. PubMed ID: 14981459 [TBL] [Abstract][Full Text] [Related]
17. Construction and high expression of retroviral vector with human clotting factor IX cDNA in vitro. Lu D; Qiu X; Zheng B; Qiu X; Xue J Sci China B; 1995 Jun; 38(6):705-12. PubMed ID: 7626200 [TBL] [Abstract][Full Text] [Related]
18. Long-term expression of human clotting factor IX from retrovirally transduced primary human keratinocytes in vivo. White SJ; Page SM; Margaritis P; Brownlee GG Hum Gene Ther; 1998 May; 9(8):1187-95. PubMed ID: 9625258 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model. Krebsbach PH; Zhang K; Malik AK; Kurachi K J Gene Med; 2003 Jan; 5(1):11-7. PubMed ID: 12516047 [TBL] [Abstract][Full Text] [Related]
20. Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion. Cherington V; Chiang GG; McGrath CA; Gaffney A; Galanopoulos T; Merrill W; Bizinkauskas CB; Hansen M; Sobolewski J; Levine PH; Greenberger JS; Hurwitz DR Hum Gene Ther; 1998 Jul; 9(10):1397-407. PubMed ID: 9681411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]